A real world therapy study assessing the prevalent of Crohn's disease of 5-ASA, corticosteroids, immunosuppressant's biologics analyze in Crohn's disease (CD) treatment in Germany
Latest Information Update: 09 Dec 2021
At a glance
- Drugs Adalimumab (Primary) ; Budesonide (Primary) ; Immunosuppressants (Primary) ; Infliximab (Primary) ; Mesalazine (Primary) ; Ustekinumab (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
Most Recent Events
- 09 Dec 2021 New trial record